At A-S Medication Solutions, we watch COVID treatment in the emergency department through the lens of access and workflow rather than bedside orders, and the pattern is clear. The ED has shifted from crisis mode to risk sorting. Physicians rely on rapid antigen tests for speed, then confirm with PCR when results will change management for high-risk patients. The old obsession with PCR cycle thresholds has faded in daily practice because CT values vary across platforms and do not translate cleanly into bedside decisions; what matters more is who is in front of you, their comorbidities and how quickly you can start treatment. The biggest practical change we see is earlier, more targeted use of antivirals for patients at heightened risk of progression, especially older adults and those with chronic conditions. ED teams are trying to identify those patients fast, start therapy within the recommended window and then hand them off into outpatient follow up without clogging beds. From our side, that has meant tightening pathways so an ED order for an antiviral can move smoothly through pharmacy, prior auth and inventory without delay. The goal now is not managing overwhelming volume. It is preventing the small subset of high-risk patients from spiraling into admission by making testing, risk assessment and antiviral access feel like one continuous, predictable chain.
Founder & Medical Director at New York Cosmetic Skin & Laser Surgery Center
Answered 4 months ago
As a dermatologist and laser surgeon in New York, I worked straight through the first chaotic COVID surges and saw how much started in the emergency department. Our ED colleagues now sort people by risk within minutes. Age, lung and heart disease, oxygen saturation, and days from symptom onset drive choices about antivirals like nirmatrelvir and ritonavir or remdesivir, not just a lab printout. The EPIC HR trial showed early oral therapy cut hospitalization or death by about 89 percent in high risk adults, which changed how I send fragile patients to the ER. We almost never use PCR cycle threshold values to decide treatment, despite all the online arguments. Assays are not standardized, and guidelines treat CT as qualitative, not a dosing knob. What matters is the person in front of you and how sick they look.
Initially, when COVID emerged in the early 2020, especially around 2021, there was a lot of confusion. We were dealing with numerous misunderstandings, conflicting guidelines, and some mismanagement due to the newness of the virus and the ever-changing information. As a general physician, I have seen how COVID care in the emergency department has improved over the past few years. Managing COVID has become better now when combined with quick decision making. One of the important steps for emergency management of COVID includes deciding which patients can benefit from antivirals. Some antivirals work best when given early, within the initial days of symptoms. Early treatment can prevent the condition from getting worse. When it comes to testing, PCR testing has been the most trusted method so far, as it detects the genetic material of viruses accurately. The first and foremost step in the emergency department is to check how the patient is breathing and what is their oxygen saturation. People who have low oxygen levels or are already suffering from any other medical conditions should be admitted immediately to prevent sudden deterioration. Oxygen therapy is used when needed, and some steroids are given only when oxygen levels are low. This happens in moderate to severe cases. Overall, COVID care in the emergency department has become better, organized, and predictable than before. The most commonly done procedure in emergency COVID cases involves: quick diagnosis, starting antivirals and monitoring breathing and providing supportive care. This progress has greatly improved patient outcomes compared to the early, confusing days of the pandemic.